Idiopathic Dacryoadenitis: Clinical Features, Histopathology, and Treatment Outcomes

Am J Ophthalmol. 2016 Mar:163:148-153.e1. doi: 10.1016/j.ajo.2015.11.032. Epub 2015 Dec 15.

Abstract

Purpose: To review the clinical and histologic features of idiopathic dacryoadenitis, and to assess prognostic factors associated with disease recurrence, treatment recalcitrance, and incomplete treatment response.

Design: Retrospective interventional case series.

Methods: setting: Tertiary referral centers.

Patients: Seventy-nine cases of biopsy-confirmed idiopathic dacryoadenitis.

Observation procedures: The following data were reviewed: age, sex, laterality, symptom onset, clinical presentation, histopathology, treatment response, and recurrence.

Main outcome measures: Rates of treatment recalcitrance, incomplete treatment response, and recurrence.

Results: Idiopathic dacryoadenitis patients had a mean age of 50 years, 57% were female, and 16% of cases were bilateral. Fifty-two percent had inflammation extending to adjacent structures on imaging. Twenty percent were recalcitrant to treatment, 17% had an incomplete treatment response, and 15% of patients had a recurrence during a mean follow-up time of 64 months. Risk factors for an incomplete treatment response were male sex (P = .01) and inflammation extending to extraocular muscle (P = .01). A clinical presentation of "classic" dacryoadenitis was a risk factor for treatment recalcitrance (P = .02). Bilateral cases were younger than unilateral cases (P = .004) and had an increased risk of recurrence (P = .05). Sclerosing cases were associated with an insidious onset of symptoms (P = .009), but neither histopathology nor the speed of symptom onset was associated with a poor prognosis.

Conclusion: Thirty-seven percent of idiopathic dacryoadenitis had a poor response to treatment and 15% of cases recurred. The prognostic factors identified in this study have not been reported previously and may inform management.

Publication types

  • Clinical Study
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Azathioprine / therapeutic use
  • Biopsy
  • Child
  • Dacryocystitis / drug therapy*
  • Dacryocystitis / pathology*
  • Drug Resistance
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Prednisolone / therapeutic use
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Tertiary Care Centers
  • Treatment Outcome
  • Triamcinolone Acetonide / therapeutic use

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Prednisolone
  • Triamcinolone Acetonide
  • Azathioprine
  • Methotrexate